ivabradine has been researched along with fluorobenzenes in 2 studies
| Studies (ivabradine) | Trials (ivabradine) | Recent Studies (post-2010) (ivabradine) | Studies (fluorobenzenes) | Trials (fluorobenzenes) | Recent Studies (post-2010) (fluorobenzenes) |
|---|---|---|---|---|---|
| 1,143 | 197 | 833 | 3,032 | 581 | 1,214 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, AL; Cleland, JG; Coletta, AP; Cullington, D | 1 |
| Elder, D; Kalra, P; Lang, CC; Pauriah, M | 1 |
2 other study(ies) available for ivabradine and fluorobenzenes
| Article | Year |
|---|---|
Clinical trials update from European Society of Cardiology meeting 2008: TIME-CHF, BACH, BEAUTIFUL, GISSI-HF, and HOME-HF.
Topics: Benzazepines; Biomarkers; Cardiology; Europe; Fatty Acids, Unsaturated; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ivabradine; Natriuretic Peptide, Brain; Pyrimidines; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Societies, Medical; Sulfonamides | 2008 |
Going for gold, from Beijing to Munich, highlights from the ESC 2008 Congress: BEAUTIFUL, GISSI-HF, and potential new therapies for acute decompensated heart failure.
Topics: Adrenergic beta-Antagonists; Benzazepines; Cardiology; Drug Therapy, Combination; Fluorobenzenes; Heart Failure; Heart Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ivabradine; Multicenter Studies as Topic; Pyrimidines; Randomized Controlled Trials as Topic; Risk Factors; Rosuvastatin Calcium; Sulfonamides | 2008 |